AI Verdict
MD has stronger fundamentals based on our AI analysis.
MDAIW vs MD Fundamental Comparison
| Metric | MDAIW | MD |
|---|---|---|
| Revenue | $19.7M | $1.9B |
| Net Income | $-7.6M | $165.4M |
| Net Margin | -38.5% | 8.6% |
| ROE | N/A | 19.1% |
| ROA | -35.4% | 7.4% |
| Current Ratio | 0.94x | 1.66x |
| Debt/Equity | N/A | 0.69x |
| EPS | $-0.29 | $1.94 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MDAIW vs MD: Frequently Asked Questions
Is MDAIW or MD a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MD has stronger fundamentals. MDAIW is rated STRONG SELL (92% confidence) while MD is rated HOLD (62% confidence). This is not investment advice.
How does MDAIW compare to MD fundamentally?
Spectral AI, Inc. has ROE of N/A vs Pediatrix Medical Group, Inc.'s 19.1%. Net margins are -38.5% vs 8.6% respectively.
Which stock pays higher dividends, MDAIW or MD?
MDAIW has a dividend yield of N/A or no dividend while MD has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MDAIW or MD for long term?
For long-term investing, consider that MDAIW has STRONG SELL rating with 92% confidence, while MD has HOLD rating with 62% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MDAIW vs MD?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MDAIW vs MD, the AI consensus favors MD based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.